Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice

Addict Sci Clin Pract. 2019 Dec 19;14(1):46. doi: 10.1186/s13722-019-0175-z.

Abstract

Background: The integration of opioid use disorder (OUD) care and competencies in graduate medical education training is needed. Previous research shows improvements in knowledge, attitudes, and practices after exposure to OUD care. Few studies report outcomes for patients with OUD in resident physician continuity practices.

Methods: A novel internal office-based opioid treatment (OBOT) program was initiated in a resident continuity clinic. Surveys of resident and staff knowledge and attitudes of OBOT were administered at baseline and 4 months. A retrospective chart review of the 15-month OBOT clinic obtained patient characteristics and outcomes.

Results: Twelve patients with OUD were seen in the OBOT clinic. Seven patients (58%) were retained in care at the end of the study period for a range of 9-15 months. Eight patients demonstrated a good clinical response. Surveys of residents and staff at 4 months were unchanged from baseline showing persistent lack of comfort in caring for patients with OUD.

Conclusions: OBOT can be successfully integrated into resident continuity practices with positive patient outcomes. Improvement in resident and staff attitudes toward OBOT were not observed and likely require direct and frequent exposure to OUD care to increase acceptance.

Keywords: Buprenorphine; Education, medical, graduate; Office based opioid treatment; Opioid-related disorder; Primary care.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Buprenorphine / therapeutic use
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Inservice Training / organization & administration
  • Internal Medicine / education*
  • Internal Medicine / organization & administration
  • Internship and Residency / organization & administration*
  • Male
  • Middle Aged
  • Narcotic Antagonists / therapeutic use
  • Opiate Substitution Treatment / methods*
  • Opioid-Related Disorders / drug therapy*
  • Retrospective Studies

Substances

  • Narcotic Antagonists
  • Buprenorphine